The Impact of Congenital, Severe, Untreated Growth Hormone (GH) Deficiency on Bone Size and Density in Young Adults: Insights from Genetic GH-Releasing Hormone Receptor Deficiency
Authors:
- 1 June 2003
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 88 (6) , 2614-2618
Abstract
GH and IGF-I have well recognized effects on bone elongation during development, but their importance for bone mineralization and structure during the growth phase are less well understood. Because children with GH deficiency are generally treated with GH, little detailed information exists in humans about the effects of long-term GH deficiency on bone development. The recently described syndrome of genetic GHRH receptor deficiency in Pakistan (dwarfism of Sindh) affords a unique opportunity to examine the question of GH deficiency on bone development because the affected patients have congenital, severe, isolated GH deficiency, which had never been treated because of societal reasons. We performed dual energy x-ray absorptiometry scans in four adult males (age, 23-30 yr) to address the question of bone mineralization. Areal bone mineral density (BMD) was low (mean Z scores: -3.3, -2.1, -3.7, and -1.7) in the lumbar spine, femoral neck, forearm, and total skeleton, respectively. This low areal BMD is in part caused by the small bone size in these dwarfed patients. When corrected for size, volumetric BMD (bone mineral apparent density) was normal to near normal (mean Z scores: -1.2, +0.8, and +0.8 for lumbar spine, femoral neck and total skeleton, respectively). We conclude that GH/IGF-I deficiency has relatively little impact on bone mineralization during the bone accretion phase. This is in marked contrast to their effect on bone elongation and overall bone size.Keywords
This publication has 31 references indexed in Scilit:
- Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adultsEuropean Journal of Endocrinology, 1999
- Long‐term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long‐term GH replacement therapyClinical Endocrinology, 1998
- Total body bone mineral measurements in children with Prader-Willi syndrome: the influence of the skull's bone mineral content per area (BMA) and of heightPediatric Radiology, 1998
- The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH‐releasing hormone receptor geneActa Paediatrica, 1997
- Effects of Physiologic Growth Hormone Therapy on Bone Density and Body Composition in Patients with Adult-Onset Growth Hormone DeficiencyAnnals of Internal Medicine, 1996
- Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouseNature Genetics, 1996
- Lower limit of body fat in healthy active menJournal of Applied Physiology, 1994
- Reduced bone mineral content in adult patients with growth hormone deficiencyEuropean Journal of Endocrinology, 1993
- New approaches for interpreting projected bone densitometry dataJournal of Bone and Mineral Research, 1992
- Clinical and Anthropometric Correlates of Bone Mineral Acquisition in Healthy Adolescent Girls*The Journal of Clinical Endocrinology & Metabolism, 1991